- Home
- GRMLW vs ARBEW Comparison
GRMLW vs ARBEW Comparison
Compare GRMLW & ARBEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GRMLW | ARBEW |
|---|---|---|
| Founded | N/A | 2015 |
| Country | United States | Israel |
| Employees | 5 | 145 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2022 | N/A |
Fundamental Metrics
Financial Performance| Metric | GRMLW | ARBEW |
|---|---|---|
| Price | $0.12 | $0.03 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 15.7K | ★ 28.2K |
| Earning Date | N/A | 03-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $768,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.08 | $0.02 |
| 52 Week High | $0.38 | $0.50 |
Technical Indicators
Market Signals| Indicator | GRMLW | ARBEW |
|---|---|---|
| Relative Strength Index (RSI) | 29.55 | 46.23 |
| Support Level | N/A | $0.02 |
| Resistance Level | $0.17 | $0.04 |
| Average True Range (ATR) | 0.03 | 0.01 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 4.55 | 40.79 |
Price Performance
Historical ComparisonAbout GRMLW Greenland Mines Ltd Warrant
Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.
About ARBEW Arbe Robotics Ltd. Warrant
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles, as well as for non-automotive uses. Geographically, the company generates maximum revenue from Sweden, and the rest from China, Hong Kong, the USA, Germany, Israel, and other markets.